HomeOwner SearchCategory Search
Visit USCOCardiovascular Drugs and Therapy [Published: 2015-03-23. Issue: vol. 29, no. 1, 2015]
Serial Registration
Copyright Title
Cardiovascular Drugs and Therapy [Published: 2015-03-23. Issue: vol. 29, no. 1, 2015]
Status
Published
on 16 Apr 2015
Year of Creation
2015
Copyright Claimant
Springer Science+Business Media LLC
Registration Number
TX0008015362
on 16 Apr 2015Copyright Summary
The U.S. Copyright record (Registration Number: TX0008015362) dated 16 Apr 2015, pertains to an electronic file (eService) titled "Cardiovascular Drugs and Therapy [Published: 2015-03-23. Issue: vol. 29, no. 1, 2015]" created in 2015. The copyright holder is Springer Science+Business Media LLC, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Springer Science+Business Media LLC.
Application Details
Registration Number
TX0008015362
Registration Date
4/16/2015
Year of Creation
2015
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Springer Science+Business Media LLC
First Publication Nation
United States
ISSN
0920-3206
Notes
Copyright Local Holdings: vol. 29, no. 1, 2015 (C.O. correspondence) Created 2015 Pub. 2015-03-23 Reg. 2015-04-21 TX0008015362 CDAV
Local Copyright Note: C.O. correspondence
Statements
Application Title Statement: Cardiovascular Drugs and Therapy
Author Statement: Springer Science+Business Media LLC employer for hire Domicile: United States Citizenship: United States Authorship: contribution(s) to a collective work
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.